Government healthcare expenditure is rising in Korea, and the costs incurred by patients in Korea exceed those incurred by patients in other Organization for Economic Co-operation and Development countries. Despite the increasing health expenditure, patient demand for services is increasing as well, so it is now becoming recognized that cancer care needs to be balanced. The most important measure in cancer care optimization is to provide high-quality care while keeping costs sustainable. The Korean Cancer Association considers the current situation of cancer therapy in Korea the foremost issue, which has led to the implementation of the nationwide ‘Right Decisions in Cancer Care’ initiative. This initiative is based on the concepts of medical professionalism in that it should be led by physicians working in the field of oncology, that education should be offered to patients and clinicians, and that it should influence healthcare policy. In this article, we introduce the nationwide ‘Right Decision in Cancer Care’ initiative and highlight the five initial items on its agenda. The agenda is open to expansion and update as the medical environment evolves and additional clinical evidence becomes available.
Citations
Citations to this article as recorded by
Addressing low-value care (LVC) in Asia: a narrative review of Choosing Wisely and other initiatives across Asia Jia Xuan Yeo, Yasuharu Tokuda, Shu Sasaki, Jay Pan, Hanin Kamaruzaman, Priya Ranganathan, Liyong Lu, Aliza Mohamad Yusof, Azarinah Izaham, C S Pramesh, Hairil Rizal Abdullah BMJ Open Quality.2026; 15(2): e003806. CrossRef
Associations of Financial Toxicity with Employment Concerns and Cancer-Related Distress: A Cross-Sectional Survey among Korean Working-Age Cancer Survivors Hyun-Ju Seo, Dal-Lae Jin, Young Ae Kim, Su Jung Lee, Seok-Jun Yoon Cancer Research and Treatment.2025; 57(3): 659. CrossRef
Relationship between patient outcomes and patterns of fragmented cancer care in older adults with gastric cancer: A nationwide cohort study in South Korea Dong-Woo Choi, Seungju Kim, Sun Jung Kim, Dong Wook Kim, Kwang Sun Ryu, Jae Ho Kim, Yoon-Jung Chang, Kyu-Tae Han Journal of Geriatric Oncology.2024; 15(2): 101685. CrossRef
Pattern of practice for postoperative management of endometrial cancer in Korea: a survey by the Korean Gynecologic Oncology Group and the Korean Radiation Oncology Group (KGOG 2028-KROG 2104) Sung Uk Lee, Joo-Young Kim, Min Kyu Kim, Young Seok Kim, Yeon Joo Kim, Keun-Yong Eom, Chan Woo Wee Journal of Gynecologic Oncology.2023;[Epub] CrossRef
The Future of Adjuvant Therapy in Renal Cell Carcinoma: Recent Insights and Prospects Hyerim Ha, Joo Han Lim Journal of Urologic Oncology.2023; 21(3): 208. CrossRef
Validation of the Korean Version of the Patient-Reported Outcomes Measurement Information System 29 Profile V2.1 among Cancer Survivors Danbee Kang, Youngha Kim, Jihyun Lim, Junghee Yoon, Sooyeon Kim, Eunjee Kang, Heesu Nam, Sungkeun Shim, Mangyeong Lee, Haesook Bok, Sang-Won Lee, Soo-Yong Shin, Jin Seok Ahn, Dongryul Oh, Juhee Cho Cancer Research and Treatment.2022; 54(1): 10. CrossRef
Comparison of Cancer-Related Spending and Mortality Rates in the US vs 21 High-Income Countries Ryan D. Chow, Elizabeth H. Bradley, Cary P. Gross JAMA Health Forum.2022; 3(5): e221229. CrossRef